The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing ...

NEW YORK — Tosoh Bioscience said Thursday that it has received 510 (k) clearance from the US Food and Drug Administration for its automated HLC-723 GR01 glycohemoglobin A1c (HbA1c) analyzer.

Fintel reports that on October 30, 2025, Wells Fargo maintained coverage of Bio-Rad Laboratories (NYSE:BIO.B) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 21.85% Upside As of ...

The company doesn't seem like it will generate pops in key fundamentals anytime soon.

The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...